My bookmarksSign up free

Commission Implementing Regulation (EU) 2024/2848 of 11 November 2024 amending Implementing Regulation (EU) No 540/2011 as regards the approval periods of the active substances fenpyrazamine and flumetralin

Commission Implementing Regulation (EU) 2024/2848 of 11 November 2024 amending Implementing Regulation (EU) No 540/2011 as regards the approval periods of the active substances fenpyrazamine and flumetralin

Implementing Regulation (EU) 2024/2848 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

ANNEX The Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in Part B, in row 25, fenpyrazamine, in the sixth column, ‘Expiration of approval’, the date is replaced by ‘15 January 2025’; (2) in Part E, in row 1, flumetralin, in the sixth column, ‘Expiration of approval’, the date is replaced by ‘15 January 2025’.

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next